Glenmede Trust Co. NA lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.1% in the third quarter, Holdings Channel.com reports. The firm owned 565,831 shares of the company’s stock after selling 6,500 shares during the period. Glenmede Trust Co. NA’s holdings in Colgate-Palmolive were worth $58,739,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently modified their holdings of the business. E Fund Management Hong Kong Co. Ltd. purchased a new position in shares of Colgate-Palmolive in the second quarter valued at $25,000. Continuum Advisory LLC lifted its holdings in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the 3rd quarter valued at $64,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.37% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Analysis on CL
Colgate-Palmolive Trading Up 1.3 %
Shares of CL stock opened at $96.59 on Wednesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a fifty day moving average price of $97.74 and a 200-day moving average price of $98.59. The company has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- How to Choose Top Rated Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
- What Does Downgrade Mean in Investing?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
- The 3 Best Retail Stocks to Shop for in August
- 2 Essential Data Center Solutions Providers Riding the AI Boom
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.